Why the study?
Do prothrombin complex concentrates improve safety and reduce thrombotic complications compared to fresh frozen plasma in patients requiring emergency reversal of vitamin K antagonist therapy?
Do prothrombin complex concentrates improve safety and reduce thrombotic complications compared to fresh frozen plasma in patients requiring emergency reversal of vitamin K antagonist therapy?
Modern prothrombin complex concentrates are preferable to fresh frozen plasma for emergency reversal of vitamin K antagonists, provided thrombotic risks are managed through careful dosing and monitoring.
No takes yet. Share an insight, caveat, or question.
Supports cautious PCC preference over FFP for VKA reversal; leaves open definitive thrombotic risk data from prospective trials.
Sørensen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: